These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 30204505

  • 21. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
    Silvestri L, Sonzogni L, De Silvestri A, Gritti C, Foti L, Zavaglia C, Leveri M, Cividini A, Mondelli MU, Civardi E, Silini EM.
    Int J Cancer; 2003 Apr 10; 104(3):310-7. PubMed ID: 12569554
    [Abstract] [Full Text] [Related]

  • 22. TNF-α and IL-10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals.
    Aroucha DC, Carmo RF, Vasconcelos LR, Lima RE, Mendonça TF, Arnez LE, Cavalcanti Mdo S, Muniz MT, Aroucha ML, Siqueira ER, Pereira LB, Moura P, Pereira LM, Coêlho MR.
    J Med Virol; 2016 Sep 10; 88(9):1587-95. PubMed ID: 26890368
    [Abstract] [Full Text] [Related]

  • 23. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
    Baghdadi I, Abu Ella K, El Shaaraway A, Elshayeb E, El-Rebey HS, El Hoseeny M, Naguib M, Nada A.
    Asian Pac J Cancer Prev; 2020 Jul 01; 21(7):2047-2053. PubMed ID: 32711431
    [Abstract] [Full Text] [Related]

  • 24. Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.
    de la Fuente S, Citores MJ, Duca A, Cisneros E, Baños I, Vilches C, Cuervas-Mons V.
    Clin Exp Med; 2017 May 01; 17(2):217-223. PubMed ID: 27083168
    [Abstract] [Full Text] [Related]

  • 25. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
    Nischalke HD, Coenen M, Berger C, Aldenhoff K, Müller T, Berg T, Krämer B, Körner C, Odenthal M, Schulze F, Grünhage F, Nattermann J, Sauerbruch T, Spengler U.
    Int J Cancer; 2012 Mar 15; 130(6):1470-5. PubMed ID: 21500195
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
    Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, Moriyama M, Otsuka M, Shiina S, Shiratori Y, Ito Y, Omata M.
    Hepatology; 2003 Jan 15; 37(1):65-71. PubMed ID: 12500190
    [Abstract] [Full Text] [Related]

  • 27. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
    Zekri Ael-R, Nassar AA, El-Din El-Rouby MN, Shousha HI, Barakat AB, El-Desouky ED, Zayed NA, Ahmed OS, El-Din Youssef AS, Kaseb AO, Abd El-Aziz AO, Bahnassy AA.
    Asian Pac J Cancer Prev; 2014 Jan 15; 14(11):6721-6. PubMed ID: 24377595
    [Abstract] [Full Text] [Related]

  • 28. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR, Bahnassy AA, Abdel-Wahab SA, Khafagy MM, Loutfy SA, Radwan H, Shaarawy SM.
    J Gastroenterol Hepatol; 2009 Mar 15; 24(3):416-28. PubMed ID: 19054267
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
    ELBassuoni MA, Abd El Fatah G, Zaghla H.
    Immunol Lett; 2015 Dec 15; 168(2):240-5. PubMed ID: 26367076
    [Abstract] [Full Text] [Related]

  • 31.  PARK2 polymorphisms predict disease progression in patients infected with hepatitis C virus.
    Al-Qahtani AA, Al-Anazi MR, Al-Zoghaibi FA, Abdo AA, Sanai FM, Al-Hamoudi WK, Alswat KA, Al-Ashgar HI, Khan MQ, Albenmousa A, Khalak H, Al-Ahdal MN.
    Ann Hepatol; 2015 Dec 15; 15(6):824-833. PubMed ID: 27740515
    [Abstract] [Full Text] [Related]

  • 32. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C, Falleti E, Cussigh A, Bitetto D, Fontanini E, Bignulin S, Cmet S, Fornasiere E, Fumolo E, Fangazio S, Cerutti A, Minisini R, Pirisi M, Toniutto P.
    J Hepatol; 2011 Apr 15; 54(4):716-22. PubMed ID: 21146242
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E, Shaker O, Abd El Aziz G, Ramadan H, Esmat G.
    Eur J Gastroenterol Hepatol; 2012 Apr 15; 24(4):458-63. PubMed ID: 22293333
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC, do Carmo RF, Moura P, Silva JL, Vasconcelos LR, Cavalcanti MS, Muniz MT, Aroucha ML, Siqueira ER, Cahú GG, Pereira LM, Coêlho MR.
    Cytokine; 2013 Jun 15; 62(3):421-5. PubMed ID: 23602201
    [Abstract] [Full Text] [Related]

  • 37. Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.
    Li Y, Xie Q, Lu F, Zhao J, Mao P, Li Z, Liu S, Zhuang H.
    Liver Int; 2010 Jan 15; 30(1):112-8. PubMed ID: 19840254
    [Abstract] [Full Text] [Related]

  • 38. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
    Zhang QX, Li SL, Yao YQ, Li TJ.
    Int J Immunogenet; 2016 Jun 15; 43(3):151-8. PubMed ID: 27122304
    [Abstract] [Full Text] [Related]

  • 39. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients.
    Sghaier I, Mouelhi L, Rabia NA, Alsaleh BR, Ghazoueni E, Almawi WY, Loueslati BY.
    Cytokine; 2017 Jan 15; 89():62-67. PubMed ID: 28340949
    [Abstract] [Full Text] [Related]

  • 40. Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients.
    Bader El Din NG, Anany MA, Dawood RM, Ibrahim MK, El-Shenawy R, El Abd YS, El Awady MK.
    Viral Immunol; 2015 Nov 15; 28(9):509-16. PubMed ID: 26505957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.